AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 11, 2023
The Delhi High Court has granted ten days’ time to the Government of India and the nation’s drug regulator to file a counter affidavit on the petitions filed by almost 28 pharma companies against the order prohibiting manufacturing, distribution and sale of 14 FDCs licensed prior to the year 1988, in the beginning of June. […]
pharmaphorum
JUNE 14, 2021
Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. The earlier HTAs, researchers and pharma companies can start that engagement the better.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 27, 2022
The adoption of digital healthcare tools in clinical research accelerated dramatically during the COVID-19 pandemic and it is expected that such tools will continue to contribute to clinical research in the future. What comes next?
Drug Discovery World
OCTOBER 16, 2023
Dr Tralau-Stewart says: “Indeed, many academic institutions have established new ways of supporting the discovery pipeline, providing tech transfer offices to support licensing, and entrepreneurship and start-up support through fundraising, accelerators, and incubators.
pharmaphorum
MAY 26, 2022
Inadequate clinical trial representations of all populations can therefore leave underrepresented groups vulnerable due to the lack of subgroup-specific data. While many pharma companies are actively working on initiatives to improve diversity in clinical trials, we still have a long way to go.
pharmaphorum
SEPTEMBER 1, 2020
The Thalidomide scandal of 1961 prompted an increase in the regulation and testing of drugs before licensing, with a new amendment to US Food and Drug Administration (FDA) rules demanding proof of efficacy and accurate disclosure of side-effects for new medications (the Kefauver-Harris Amendment) being implemented in 1962.
Drug Discovery World
OCTOBER 7, 2022
TH : Increasingly, large pharma companies need scale, agility and access to academic partnerships to succeed. This funding is distributed between funding discovery research at our core institutes, and at universities around the UK, clinical research, cancer grand challenges, and translational research. .
Expert insights. Personalized for you.
133 
Let's personalize your content